Research Options:

Week of Expected Pricing 7/16/2021
Company Name SIGHT SCIENCES INC
Proposed Ticker SGHT
CUSIP N/A
Business Description Our mission is to transform ophthalmology and optometry through the development and commercialization of proprietary devices that target the underlying causes of the world’s most prevalent eye diseases. We are passionate about improving patients’ lives. Our business philosophy is grounded in the following principles: comprehensively understanding disease physiology; developing products that are intended to restore natural physiological functionality to diseased eyes; developing and marketing products that achieve superior effectiveness versus current treatment paradigms while minimizing complications or side effects; providing intuitive.
Lead Underwriter BofA Securities, Inc, Morgan Stanley & Co. LLC
Co-Managers Citigroup Global Markets Inc, Piper Sandler & Co
Initial Shares 69,80,000
Revised Initial Shares 1,00,00,000
Initial Price $23.00-$24.00
Revised Price N/A
Final Price $24.00
Final Ticker SGHT

 

 

   
  © 2024 ICE Data Services. All rights reserved.